Thalidomide in patients with myelofibrosis with myeloid metaplasia.

被引：0
|
作者：
Barosi, G
Grossi, A
Comotti, B
Marchetti, M
机构：
[1] Policlin San Matteo, IRCCS, Lab Med Informat, I-27100 Pavia, Italy
[2] Policlin S Pietro, Hematol & Oncol Unit, Bergamo, Italy
[3] Policlin Careggi, Div Hematol, Florence, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3223
引用
收藏
页码：746A / 746A
页数：1
相关论文
共 50 条
  • [1] A combination of low dose thalidomide with prednisone in myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Li, CY
    Steensma, DP
    Pardanani, A
    Elliott, MA
    Kaufmann, SH
    Gray, L
    Schroeder, GS
    Tefferi, A
    BLOOD, 2002, 100 (11) : 71A - 71A
  • [2] Responses to thalidomide combined with prednisone therapy for myelofibrosis with myeloid metaplasia.
    Qian, Shenxian
    Tan, Junfeng
    Shi, Pengfei
    Gao, Gaqian
    BLOOD, 2006, 108 (11) : 1035A - 1035A
  • [3] Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study
    Piccaluga, PP
    Visani, G
    Pileri, SA
    Ascani, S
    Grafone, T
    Isidori, A
    Malagola, M
    Finelli, C
    Martinelli, G
    Ricci, P
    Baccarani, M
    Tura, S
    LEUKEMIA, 2002, 16 (09) : 1609 - 1614
  • [4] Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study
    PP Piccaluga
    G Visani
    SA Pileri
    S Ascani
    T Grafone
    A Isidori
    M Malagola
    C Finelli
    G Martinelli
    P Ricci
    M Baccarani
    S Tura
    Leukemia, 2002, 16 : 1609 - 1614
  • [5] Medical progress: Myelofibrosis with myeloid metaplasia.
    Tefferi, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (17): : 1255 - 1265
  • [6] Circulating endothelial progenitor cells in patients with myelofibrosis with myeloid metaplasia.
    Rosti, V
    Massa, M
    Ramajoli, I
    Campanelli, R
    Pecci, A
    Viarengo, G
    Marchetti, M
    Barosi, G
    BLOOD, 2003, 102 (11) : 663A - 663A
  • [7] Multiple courses of splenic irradiation in patients with myelofibrosis with myeloid metaplasia.
    Zelig, O
    Tochner, Z
    Weshler, Z
    Rachmilewitz, EA
    BLOOD, 1999, 94 (10) : 293B - 293B
  • [8] Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia
    Barosi, G
    Grossi, A
    Comotti, B
    Musto, P
    Gamba, G
    Marchetti, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 78 - 83
  • [9] Thalidomide: no benefit in myelofibrosis with myeloid metaplasia
    Bonn, D
    LANCET ONCOLOGY, 2003, 4 (02): : 70 - 70
  • [10] Thalidomide therapy for myelofibrosis with myeloid metaplasia
    Thomas, DA
    Giles, FJ
    Albitar, M
    Cortes, JE
    Verstovsek, S
    Faderl, S
    O'Brien, SM
    Garcia-Manero, G
    Keating, MJ
    Pierce, S
    Zeldis, J
    Kantarjian, HM
    CANCER, 2006, 106 (09) : 1974 - 1984
12345